Petra Pharma Receives $48,000,000 Series A Financing Round

  • Feed Type
  • Date
    1/7/2016
  • Company Name
    Petra Pharma
  • Mailing Address
    450 E. 29th St. New York, NY 10016 USA
  • Company Description
    Petra Pharma’s approach interrogates the novel enzyme targets responsible for a variety of important cellular processes, including cell division, growth, trafficking and signaling to develop therapies to improve patient health.
  • Website
    Undisclosed
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $48,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds will be used to develop small molecule inhibitors for the treatment of cancer and metabolic diseases in alliance with Weill Cornell Medicine.
  • M&A Terms
  • Venture Investor
    Accelerator Ventures
  • Venture Investor
    Investor
  • Venture Investor
    Johnson & Johnson Development Corporation
  • Venture Investor
    AbbVie Biotech Ventures
  • Venture Investor
    Pfizer Venture Investments
  • Venture Investor
    ARCH Venture Partners

Trending on Xconomy